Kalvista Pharmaceuticals, Inc. - KALV

Include option trades

Include indirect trades

EDGAR CIK

1 Month 3 Month 6 Month 1 Year 2 Years

Buy Breakdown

No buy transactions for this time period.

Transaction	Filed	Name	Type	Shares @ Price	Value	Balance change		Ownership
07/09/2025	07/10/2025	Palleiko Benjamin L CHIEF EXECUTIVE OFFICER CEO Director	Sell	-32,979 @ $15.69	($517,522.96)	369,595	(-8.19%)	Direct
07/09/2025	07/10/2025	Yea Christopher CHIEF DEVELOPMENT OFFICER Officer	Sell	-30,250 @ $15.69	($474,698.12)	127,939	(-19.12%)	Direct